Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.20 -0.05 (-0.13%)
As of: Sep 30, 2026 · 3:59 PM EDT

Xenon Pharmaceuticals (XENE) Short term Debt (2017 - 2020)

Updated

Xenon Pharmaceuticals (XENE) reported Short term Debt of $15.68 million for Q1 2020, up 237.1% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Short term Debt (2017 - 2020) Analysis & Trends

At the end of FY2019, Xenon Pharmaceuticals posted Short term Debt of $4.65 million.

  • By year, Short term Debt came in at $700,000 in FY2017.
  • Per Business Quant data, the three quarters before Q1 2020 came in at $4.65 million (Q4 2019), $3.62 million (Q3 2019) and $2.07 million (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 15.68 Mn
Dec 31, 2019 4.65 Mn
Sep 30, 2019 3.62 Mn
Jun 30, 2019 2.07 Mn
Mar 31, 2018 1.40 Mn
Dec 31, 2017 700,000.00
API Access

Xenon Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=XENE&period=max&api_key=YOUR_API_KEY